Kolexia
Tran Albert
Gastro-entérologie
Hôpital De l'Archet
Nice, France
241 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite C Fibrose Cirrhose du foie Hépatite C chronique Carcinome hépatocellulaire Carcinomes Stéatose hépatique non alcoolique Stéatose hépatique

Industries

Gilead
28 collaboration(s)
Dernière en 2023
A+A
10 collaboration(s)
Dernière en 2023
Ipsen
8 collaboration(s)
Dernière en 2021
Abbvie
7 collaboration(s)
Dernière en 2022

Dernières activités

RELATIVITY-106: A Phase 1/2, Safety Confirmation, Placebo-controlled, Randomized Study of Nivolumab in Combination With Relatlimab and Bevacizumab in Treatment-naive Advanced/Metastatic Hepatocellular Carcinoma
Essai Clinique (BMS)   07 mars 2024
NATiV3: A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) and Fibrosis Stages F2 and F3
Essai Clinique (Inventiva Pharma)   24 janvier 2024
Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High Fat, High Fructose, High Cholesterol Diet Mouse Model.
bioRxiv : the preprint server for biology   11 janvier 2024
SALON DU LYCÉEN ET DE L'ÉTUDIANT
Youtube @ UFR médecine   22 novembre 2023
Osteopontin-driven T-cell accumulation and function in adipose tissue and liver promoted insulin resistance and MAFLD.
Obesity (Silver Spring, Md.)   28 septembre 2023
Mid-Infrared Spectroscopy as a New Tool for Ruling Out Spontaneous Bacterial Peritonitis: A Proof-of-Concept Study.
Biomedicines   09 mars 2023
Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial.
JHEP reports : innovation in hepatology   15 février 2023
Impaired Function of Solute Carrier Family 19 Leads to Low Folate Levels and Lipid Droplet Accumulation in Hepatocytes.
Biomedicines   31 janvier 2023
HEPATHER: Therapeutic Option for Hepatitis B and C: a French Cohort
Essai Clinique (BMS)   30 janvier 2023
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial.
Liver cancer   04 octobre 2022